Vital Signs - 10 July 2006

 


This issue of Vital Signs, released on July 10, 2006, provides a strategic overview of the increased use of direct to consumer marketing within the medical device industry and compares / contrasts it to the same practice within the pharmaceutical industry. Additionally, an emerging company profile is provided on Small Bone Innovations, a company specializing in the development and manufacturing of products that specifically focus on small bones and joints. Reimbursement and regulatory news from the FDA and CMS are also provided for the week of June 26 - June 30, 2006.
USD 1,500

* Required Fields

USD 1,500

PAY BY INVOICE

Be the first to review this product

Table of Contents

Vital Signs - 10 July 2006Direct to Consumer Advertising for Medical Devices: Lessons Learned from PharmaDirect to Consumer Advertising for Medical Devices: Lessons Learned from Pharma




Related Research

Release Date : 08-Aug-17

Region : North America

Release Date : 31-Jul-17

Region : North America

Release Date : 27-Jul-17

Region : North America

Release Date : 27-Jul-17

Region : North America

Release Date : 24-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.